<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004109A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004109</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13934271</doc-number><date>20130703</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>28</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>7</main-group><subgroup>08</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>28</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>7</main-group><subgroup>08</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>4241331</main-classification><further-classification>4241451</further-classification><further-classification>5303892</further-classification><further-classification>530326</further-classification><further-classification>4241581</further-classification><further-classification>5303873</further-classification><further-classification>5303879</further-classification></classification-national><invention-title id="d0e43">Methods Of Reducing Eosinophil Levels</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>13177221</doc-number><date>20110706</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8501176</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13934271</doc-number></document-id></child-doc></relation></continuation><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12600017</doc-number><date>20100726</date></document-id><parent-status>ABANDONED</parent-status><parent-pct-document><document-id><country>WO</country><doc-number>PCT/US08/06156</doc-number><date>20080514</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13177221</doc-number></document-id></child-doc></relation></continuation><us-provisional-application><document-id><country>US</country><doc-number>60924422</doc-number><date>20070514</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>60924832</doc-number><date>20070601</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>60935005</doc-number><date>20070720</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61064612</doc-number><date>20080314</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Medlmmune, LLC</orgname><address><city>Gaithersburg</city><state>MD</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>BIOWA, INC.</orgname><address><city>Princeton</city><state>NJ</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Koike</last-name><first-name>Masamichi</first-name><address><city>West Windsor</city><state>NJ</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>SPITALNY</last-name><first-name>George L.</first-name><address><city>Yardley</city><state>PA</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>WHEELER</last-name><first-name>Alistair</first-name><address><city>Northborough</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>WHITE</last-name><first-name>Barbara</first-name><address><city>Finksburg</city><state>MD</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Medlmmune, LLC</orgname><role>02</role><address><city>Gaithersburg</city><state>MD</state><country>US</country></address></addressbook></assignee><assignee><addressbook><orgname>Biowa, Inc.</orgname><role>02</role><address><city>Princeton</city><state>NJ</state><country>US</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention relates to a method of reducing the numbers of eosinophils in a human subject comprising administration to a subject an IL-5R binding molecule that comprises (a) a region that specifically binds to the IL-5R and (b) an immunoglobulin Fc region. In a specific embodiment, a method of the invention reduces the number of eosinophils in blood, bone marrow, gastrointestinal tract (e.g. esophagus, stomach, small intestine and colon), or lung.</p></abstract></us-patent-application>